These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3201525)

  • 1. An approach to forecast aminoglycoside-related nephrotoxicity from routinely collected clinical data.
    Kubota K; Suganuma T; Sasaki T; Ishizaki T
    Ther Drug Monit; 1988; 10(4):410-20. PubMed ID: 3201525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients.
    Schentag JJ; Plaut ME; Cerra FB
    Antimicrob Agents Chemother; 1981 May; 19(5):859-66. PubMed ID: 7294770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled comparison of gentamicin and tobramycin nephrotoxicity.
    Matzke GR; Lucarotti RL; Shapiro HS
    Am J Nephrol; 1983; 3(1):11-7. PubMed ID: 6340504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical assessment of a published model to predict aminoglycoside-induced nephrotoxicity.
    Garrison MW; Rotschafer JC
    Ther Drug Monit; 1989; 11(2):171-5. PubMed ID: 2718222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of estimating individual pharmacokinetic data for aminoglycoside therapy in seriously ill patients.
    Denaro CP; Ravenscroft PJ
    Aust N Z J Med; 1987 Oct; 17(5):526-32. PubMed ID: 3446165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoglycoside pharmacokinetics: dosage requirements and nephrotoxicity in trauma patients.
    Townsend PL; Fink MP; Stein KL; Murphy SG
    Crit Care Med; 1989 Feb; 17(2):154-7. PubMed ID: 2914447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.
    Smith CR; Lipsky JJ; Laskin OL; Hellmann DB; Mellits ED; Longstreth J; Lietman PS
    N Engl J Med; 1980 May; 302(20):1106-9. PubMed ID: 6988713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical utility of a published nomogram to predict aminoglycoside nephrotoxicity.
    Lam YW; Arana CJ; Shikuma LR; Rotschafer JC
    JAMA; 1986 Feb; 255(5):639-42. PubMed ID: 3944964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable pharmacokinetics of extended interval tobramycin or gentamicin among critically ill patients undergoing continuous venovenous hemofiltration.
    Chuk AC; Saeed F; Kousar N; Burrill S; Barns B; Rickrode G; Fu J; Katrych O; Saunders-Hao P; Block C; Lahey T
    Clin Nephrol; 2015 Oct; 84(4):214-21. PubMed ID: 26308080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 201 critically ill patients.
    Schentag JJ; Cerra FB; Plaut ME
    Antimicrob Agents Chemother; 1982 May; 21(5):721-6. PubMed ID: 7103453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside nephrotoxicity: a double blind prospective randomized study of gentamicin and tobramycin.
    Feig PU; Mitchell PP; Abrutyn E; Brock SM; Carney WR; Graeber CW; Horak E; Lyons RW; Maher JF
    J Antimicrob Chemother; 1982 Sep; 10(3):217-26. PubMed ID: 6754682
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation between nephrotoxicity and pharmacokinetic parameters of gentamicin.
    el-Sayed YM
    J Clin Pharm Ther; 1994 Aug; 19(4):267-71. PubMed ID: 7989408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycoside nephrotoxicity in obstructive jaundice.
    Desai TK; Tsang TK
    Am J Med; 1988 Jul; 85(1):47-50. PubMed ID: 3389381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of aminoglycoside serum assays on clinical decisions and renal toxicity.
    Arroyo JC; Milligan WL; Davis J; Mitchell D
    South Med J; 1986 Mar; 79(3):272-6. PubMed ID: 3513326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial pharmacokinetic dosing of aminoglycosides: a community hospital experience.
    Hoffa DE
    Ther Drug Monit; 1989 Sep; 11(5):574-9. PubMed ID: 2815234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens.
    Barletta JF; Johnson SB; Nix DE; Nix LC; Erstad BL
    J Trauma; 2000 Nov; 49(5):869-72. PubMed ID: 11086778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study.
    Kumin GD
    JAMA; 1980 Oct; 244(16):1808-10. PubMed ID: 7420681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between aminoglycoside-induced nephrotoxicity and auditory toxicity.
    Smith CR; Lipsky JJ; Lietman PS
    Antimicrob Agents Chemother; 1979 Jun; 15(6):780-2. PubMed ID: 475363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The absence of nephrotoxicity and differential nephrotoxicity between tobramycin and gentamicin.
    Kepczyk T; Ryan PJ; McAllister K; Otraje J
    South Med J; 1990 Oct; 83(10):1149-52. PubMed ID: 2218653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.